Clinical Trials Directory

Trials / Unknown

UnknownNCT00492739

Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients

Induction and Maintenance of Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients: a Retrospective and Prospective Nationwide Study in Switzerland

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
University Hospital, Geneva · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Varicella is a vaccine-preventable disease, which can be severe in immunosuppressed children. Currently, the (live) vaccine is not recommended in pediatric orthotopic liver transplant recipients. Furthermore, protection due to naturally acquired immunity to VZV or post-immunization isn't well described in this population.The questions asked are: * What is the influence of the immunosuppression required after orthotopic liver transplantation (OLT) on the maintenance of VZV-specific immunity elicited by wild-type varicella infection before OLT transplantation? * What is the influence of the immunosuppression required after OLT on VZV-specific immunity elicited by varicella immunization before OLT transplantation? * What is the influence of the residual immunosuppression at ≥ 12 months after OLT transplantation on the induction of VZV-specific B and T cell responses elicited by VZV vaccination after OLT transplantation? * What is the influence of the residual immunosuppression at ≥ 12 months after OLT transplantation on the persistence / waning of B and T cell responses elicited by VZV vaccination?

Detailed description

VZV vaccine given to pediatric liver transplant recipients at least one year after transplantation if tehy fulfill inclusion criteria and give informed consent.

Conditions

Interventions

TypeNameDescription
BIOLOGICALVaccination with VZV vaccineVaricella vaccination 2 doses 2 months apart.

Timeline

Start date
2007-06-01
Primary completion
2022-04-01
Completion
2025-12-01
First posted
2007-06-27
Last updated
2020-09-18

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT00492739. Inclusion in this directory is not an endorsement.